Understanding the precise role of TMEM44-AS1 in glioma and activation of the Myc signaling pathway will improve our knowledge about the progression of human gliomas and enable novel therapeutic strategies against glioma. This evidence concerns the gene TMEM44 and central nervous system cancer.